Pediatric GERD Treatment
Start with lifestyle modifications as first-line therapy for all pediatric GERD patients, reserving pharmacologic therapy with PPIs or H2RAs only for confirmed GERD that fails to respond to conservative measures after 2-4 weeks. 1, 2
Treatment Algorithm by Age Group
Infants (<12 months)
Lifestyle and Feeding Modifications (First-Line)
For breastfed infants: Implement a 2-4 week trial of maternal dietary elimination excluding at least milk and egg proteins, as cow's milk protein allergy can mimic GERD in up to 42-58% of cases 3, 4, 5
For formula-fed infants: Trial an extensively hydrolyzed protein or amino acid-based formula for 2-4 weeks 3, 4
Thickened feedings: Add up to 1 tablespoon of dry rice cereal per ounce of formula to reduce reflux symptoms 3, 4
Feeding adjustments: Reduce feeding volume while increasing frequency to minimize gastric distension 3, 1
Positioning: Keep infants completely upright for at least 30 minutes after meals when awake; avoid prone positioning during sleep 1, 4
Pharmacologic Therapy (Second-Line - Only for Confirmed GERD)
H2 Receptor Antagonists: Ranitidine (5-10 mg/kg/day divided in 2-3 doses) or famotidine (1 mg/kg/day divided in 2 doses) are effective first-line medications 2, 6
Proton Pump Inhibitors: For moderate-to-severe symptoms or erosive esophagitis, use omeprazole (0.7-3.3 mg/kg/day), lansoprazole (0.7-3 mg/kg/day), or esomeprazole (0.7-3.3 mg/kg/day) 2, 5
Treatment duration: Limit acid suppression to 4-8 weeks when evaluating treatment efficacy 3, 2
Children (>12 months) and Adolescents
Lifestyle Modifications (First-Line)
Dietary changes: Avoid trigger foods including spicy foods, chocolate, caffeine, and acidic foods 1, 2
Weight management: Recommend weight loss if overweight or obese 2
Meal timing: Avoid eating within 2-3 hours before bedtime to minimize nocturnal reflux 1
Positioning: Elevate the head of the bed or maintain upright position after meals; prone positioning can be beneficial in children older than 1 year 2, 4, 7
Behavioral: For adolescents, avoid smoking and alcohol 2
Adjunctive measures: Encourage chewing sugarless gum after meals to increase saliva production and neutralize acid 1, 2
Pharmacologic Therapy (Second-Line)
For mild symptoms: Trial H2RA (famotidine 1 mg/kg/day divided in 2 doses) for 4 weeks 2
For moderate-to-severe symptoms or erosive esophagitis: Use PPI (omeprazole 0.7-3.3 mg/kg/day, lansoprazole 0.7-3 mg/kg/day, or esomeprazole 0.7-3.3 mg/kg/day) 2, 8
Treatment duration: Typically 4-8 weeks, with reassessment of response 3, 2
Critical Warnings and Pitfalls
Avoid Overtreatment with Acid Suppressants
Do NOT use PPIs or H2RAs for uncomplicated physiologic reflux ("happy spitters") - these medications are indicated only for confirmed GERD with troublesome symptoms or complications 1, 4
Do NOT use acid suppressive therapy solely for chronic cough without other GERD symptoms, as evidence does not support this practice 3
Serious adverse events with prolonged PPI use include increased risk of community-acquired pneumonia, gastroenteritis, candidemia, vitamin B12 deficiency, bone fractures, tubulointerstitial nephritis, and Clostridium difficile infection 3, 2, 9
H2RA-specific risks: Tachyphylaxis can occur within 6 weeks of initiation; cimetidine may cause liver disease and gynecomastia 2
When to Escalate Care
Refer to pediatric gastroenterology if symptoms fail to respond to optimal medical therapy after 4-8 weeks 3, 2
Consider upper endoscopy with esophageal biopsy for patients with warning signs including poor weight gain, unexplained anemia, recurrent pneumonia, hematemesis, or failure to respond to pharmacologic therapy 3, 4
Surgical fundoplication should be reserved only for severe cases that have failed pharmacologic treatment or have severe risk of aspiration 1
Monitoring and Follow-Up
Reassess treatment response after 4-8 weeks of therapy and consider alternative diagnoses if symptoms persist 3, 2
Do not continue acid suppression beyond 12 months without specialist consultation, as long-term safety data are limited 4, 8
Monitor for medication side effects including decreased urination, bloody urine, severe diarrhea, joint pain, or new rashes during PPI therapy 9